Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 2102.HK
Valuation Positive
71%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q1 Q2 Δ in %
Current Ratio 0.00 8.15 8.15
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 63.25 -0.62 -1.69
Naive Interpretation member
2 Per Share
Metric Q1 Q2 Δ in %
Book Value 0.00 0.45 0.45
Cash 0.00 0.05 0.05
Capex -100.00 < 0.005 < 0.005
Free Cash Flow -100.00 < 0.005 < 0.005
Revenue 100.00 0.13 0.07
Naive Interpretation member
3 Profitability
Metric Q1 Q2 Δ in %
Gross Margin 0.00 0.24 0.24
Operating Margin -6.15 0.07 0.08
ROA 100.00 0.02 < 0.005
ROE 100.00 0.02 < 0.005
ROIC 85.78 0.02 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 2102.HK is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 2102.HK is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 2102.HK is permitted for members.